Clinical Trials Directory

Trials / Terminated

TerminatedNCT02419976

Electronic Nose Identification of Fasting and Non-fasting Breath Profiles

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
879 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators will study a noninvasive no risk process by which the investigators can quickly screen and assess for fasting and non-fasting states in individuals scheduled for routine endoscopy.

Detailed description

The investigators will study a noninvasive no risk process by which we can quickly screen and assess for fasting and non-fasting states in individuals scheduled for routine endoscopy. In non-fasting individuals, the risk of a sedation related complication such as aspiration increases and often the procedure must be aborted and repeated on another day following more prolonged fasting and medication administration. This adds to increased cost and delay to patient care.

Conditions

Interventions

TypeNameDescription
OTHERa breath analysis using the Aeonoseusing the Aeonose per standard acquisition protocol which spans 15 minutes of which the individuals breaths normally through a sterile disposable mouthpiece with sterile disposable air filters for 5 minutes during signal acquisition while wearing a nose plug. This will be completed in the office setting prior to their endoscopic procedure. Following their scheduled standard of care endoscopic procedure the patient will be allowed to consume a standardized refreshment (such as juice or soda) prior to discharge from the post procedure area. These refreshments are already provided as standard care. The participant will return to the office setting and repeat the same breath analysis acquisition process that was done prior to the procedure.
DEVICEAeonose

Timeline

Start date
2015-02-01
Primary completion
2024-06-20
Completion
2024-06-20
First posted
2015-04-17
Last updated
2026-01-26
Results posted
2026-01-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02419976. Inclusion in this directory is not an endorsement.